Sarcoma & rare tumors · 8 June 2024

Comparable Long-Term Survival Prognoses in Gastrointestinal Neuroendocrine Neoplasms

Endoscopic treatment and surgery show similar overall and cancer-specific survival rates in gastrointestinal neuroendocrine neoplasms. Endoscopic treatment may offer a better cancer-specific survival in certain cases such as stage I tumors and those smaller than 10mm. Both treatment options are viable for patients, with endoscopic treatment as a potential alternative for those hesitant about surgery.

Journal Article by Gao F and Xu X in Surg Laparosc Endosc Percutan Tech

read the whole article in Surg Laparosc Endosc Percutan Tech

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Sarcoma & rare tumors.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

The latest stitches

Ann Surg Oncol26 Oct 2026

SSTR PET finds more distant disease in GEP-NETs

In this 24-year surgical cohort, SSTR PET identified bone and retroperitoneal nodal metastases more often than Octreoscan—findings that may matter for operative planning.

Ann Surg Oncol11 May 2026

Mapping Surgical Evidence for GEP-NETs

Surgical management of gastro-entero-pancreatic neuroendocrine tumors is inconsistent, highlighting the need for clearer guidelines.

BMC Surg30 Mar 2026

Gallium-68 PET for Pancreatic Neuroendocrine Tumors: Limited Sensitivity

A study shows Gallium-68 DOTATATE PET has high specificity but low sensitivity in identifying lymph node metastases in pancreatic neuroendocrine tumors, affecting surgical decisions.

All papers in Sarcoma & rare tumors →